For both luminal A (ER and/or PR+, HER2−) and triple-negative (ER−, PR− and HER2−) BC, the average Pfn1 immunoreactivity was significantly lower in low NG tumours than higher nuclear grade tumours. The gene discussed is ERBB2; the disease is breast cancer.